Ludwig Hantson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Marlborough, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
By: Patrick R. O'Neil, attorney-in-fact For: Ludwig Hantson
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ludwig Hantson

Form 4 holding CEO, Director

ALEXION PHARMACEUTICALS, INC.

Security class
Common Stock, par value $.0001 per share
Shares / value
9,098
Estimated value
$1,610,346
Report date
21 Jul 2021
Price
$177.00
Ownership
Direct
Form 4 holding Director

IONIS PHARMACEUTICALS INC

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
10,753
Estimated value
Report date
04 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO, Director

ALEXION PHARMACEUTICALS, INC.

Security class
Option to Purchase Common Stock
Shares / value
0
Estimated value
Report date
21 Jul 2021
Price
$155.01
Ownership
Direct
Underlying class
Common Stock, par value $.0001 per share
Underlying amount
Form 4 holding Director

HOLOGIC INC

Security class
Non-qualified Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
07 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Ludwig Hantson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .